510(k) Report

510(k) · Cleared

Cleared

Cruiser 18 Guidewire

K102211510(k) SpecialCleared Sep 3, 201029-day reviewClass II21 CFR 870.1330

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Brivant, Ltd. · DQX Wire, Guide, Catheter

Cleared on Sep 3, 2010 as substantially equivalent to K060551 (Brivant Limited, 2006) and 1 other predicate after a 29-day review. Its family tree reaches back 6 generations to 1997. 1 later device descends from it.

Decided
Sep 3, 2010
Review
29 days
Class
Class II
Product code
DQX
Recalls
None
Predicates
2

Its longest line of descent runs back 6 generations to K970376 (1997). 14 ancestors in all, the oldest K893626 (1989). 1 later device descends from it, 1 citing it directly.

Other ancestors, by year clearedDescendants, by year cleared 2008: 1 other ancestor2003: 3 other ancestors2001: 1 other ancestor1995: 1 other ancestor1991: 1 other ancestor1989: 1 other ancestor2012: 1 descendant clearedK970376 · Ptca Guidewire · Lake Region Mfg., Inc. · 1997K011968 · Streerable Ptca Guidewire · Lake Region Mfg., Inc. · 2001 · recalledK022813 · Steerable Guidewire · Lake Region Mfg., Inc. · 2003K040345 · Modification to Nitrex Nitinol Guidewire · Ev3, Inc. · 2004K050756 · Skipper and Skipper Race Guidewire · Invatec Innovative Technologies, S.R.L. · 2005K060551 · Brivant Guidewire · Brivant Limited · 20061990200020102020
Other ancestors, by generationDescendants, by generation 1 generation back: 1 other ancestor2 generations back: 2 other ancestors3 generations back: 2 other ancestors4 generations back: 3 other ancestors 1 generation forward: 1 descendant K060551 · Brivant Guidewire · Brivant Limited · 2006K050756 · Skipper and Skipper Race Guidewire · Invatec Innovative Technologies, S.R.L. · 2005K040345 · Modification to Nitrex Nitinol Guidewire · Ev3, Inc. · 2004K022813 · Steerable Guidewire · Lake Region Mfg., Inc. · 2003K011968 · Streerable Ptca Guidewire · Lake Region Mfg., Inc. · 2001 · recalledK970376 · Ptca Guidewire · Lake Region Mfg., Inc. · 1997−50
  1. Root · 6 generations backK970376 Ptca GuidewireLake Region Mfg., Inc. · 1997
  2. 5 generations backK011968 Streerable Ptca GuidewireLake Region Mfg., Inc. · 2001 · Recalled
  3. 4 generations backK022813 Steerable GuidewireLake Region Mfg., Inc. · 2003
  4. 3 generations backK040345 Modification to Nitrex Nitinol GuidewireEv3, Inc. · 2004
  5. 2 generations backK050756 Skipper and Skipper Race GuidewireInvatec Innovative Technologies, S.R.L. · 2005
  6. 1 generation backK060551 Brivant GuidewireBrivant Limited · 2006
  7. This deviceK102211 Cruiser 18 GuidewireBrivant, Ltd. · 2010
  8. Descendant · cites it directly · 0 of its ownK120137 Victory Guidewire (32 Models)Brivant, Ltd. · 2012

Most influential descendants

Showing 1 of 1 · See all
  • K120137Victory Guidewire (32 Models)Brivant, Ltd. · 2012 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−6K970376Ptca GuidewireLake Region Mfg., Inc.1997—
−5K011968Streerable Ptca GuidewireLake Region Mfg., Inc.20012
−4K022813Steerable GuidewireLake Region Mfg., Inc.2003—
−3K040345Modification to Nitrex Nitinol GuidewireEv3, Inc.2004—
−2K050756Skipper and Skipper Race GuidewireInvatec Innovative Technologies, S.R.L.2005—
−1K060551Brivant GuidewireBrivant Limited2006—
0 (this device)K102211Cruiser 18 GuidewireBrivant, Ltd.2010—
+1K120137Victory Guidewire (32 Models)Brivant, Ltd.2012—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
198910
199110
199510
200110
200330
200810

Descendants by year cleared

Year clearedDevicesWith a Class I recall
201210
FIG. 1 — Lineage of K102211, 1997–2012Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in DQX? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new DQX device

  1. #1 K213854 SavvyWirescore 15.7 · 10 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (2)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K060551Brivant Guidewire
Summary page 1
…evices Manufacturer 510k Date Brivant Ltd, Brivant Guidewire K060551 07 Jun 2006 Brivant Ltd, Courier Guidewire K073082 09 Jan 2008 Princi…
Brivant Limited2006—
*K073082CPS Courier Guidewire
Summary page 1
…Brivant Ltd, Brivant Guidewire K060551 07 Jun 2006 Brivant Ltd, Courier Guidewire K073082 09 Jan 2008 Principle of The Cruiser-lB Guidewire is operated manually by a manual process Operation Comparison of…
Brivant, Ltd.2008—

Also cleared against K060551: 4 other devices →

What descends from it? (1)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K120137Victory Guidewire (32 Models)Brivant, Ltd.20120

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 13 years and passes through 5 companies; a new generation was cleared every 1.6 years on median.
  • 1 of the 14 ancestors has a recall of any class.
  • Of its descendants, K120137 (Brivant, Ltd., 2012) has gone furthest, with 0 descendants of its own.
  • 4 other devices also cite its predicate K060551.

How does its category compare?

All DQX devices

DQX Wire, Guide, Catheter: FDA decisions, review times, recalls and adverse event reports over 20 years. 2010, this device’s year, is highlighted.

FDA decisions per year · DQX

10in 2025

2007: 142008: 192009: 182010: 212011: 182012: 202013: 182014: 182015: 152016: 142017: 192018: 192019: 132020: 142021: 62022: 152023: 102024: 112025: 102026 (partial year): 12
2007high 21 (2010) · low 6 (2021)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · DQX

177in 2025

2007: 85 days median2008: 87 days median2009: 87 days median2010: 63 days median2011: 43 days median2012: 62 days median2013: 119 days median2014: 103 days median2015: 112 days median2016: 179 days median2017: 85 days median2018: 114 days median2019: 173 days median2020: 106 days median2021: 161 days median2022: 212 days median2023: 136 days median2024: 134 days median2025: 177 days median2026 (partial year): 145 days median
2007high 212 (2022) · low 43 (2011)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · DQX

3in 2024

2007: 122008: 72009: 492010: 342011: 32012: 52013: 7, 4 Class I2015: 12016: 2, 2 Class I2017: 172018: 92019: 22020: 1, 1 Class I2024: 32026 (partial year): 4, 1 Class I
2007high 49 (2009) · low 0 (2014)2026

Class I (8 since 2007) Class II/III not classified

Adverse event reports per year · DQX

2,178in 2025

2007: 7602008: 7152009: 6872010: 9872011: 1,3112012: 1,3372013: 1,4742014: 1,3232015: 1,3232016: 1,4662017: 1,5242018: 1,7372019: 1,6792020: 1,5362021: 1,7132022: 1,6472023: 2,0682024: 2,2102025: 2,178
2007high 2,210 (2024) · low 687 (2009)2025

MAUDE reports naming product code DQX, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
2007148512760
200819877715
2009188749687
2010216334987
2011184331,311
2012206251,337
2013181197 (4)1,474
20141810301,323
20151511211,323
2016141792 (2)1,466
20171985171,524
20181911491,737
20191317321,679
2020141061 (1)1,536
2021616101,713
20221521201,647
20231013602,068
20241113432,210
20251017702,178
2026121454 (1)—

What is it indicated for?

The Cruiser-18 Guidewires are intended for use in the peripheral vasculature

Contraindlications: The Cruiser-18 guide wire is not intended for use in the coronary or cerebral vasculature.

Patients judged not acceptable for percutaneous intervention (PPCI)

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K102211: Cruiser 18 Guidewire.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K102211

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026